Atara rises on plan to lay off staff
** Cell therapy developer Atara's ATRA.O shares rise 5.1% to $14.69, its highest in more than eight months ** Co to lay off 29% of staff, retaining about 15 employees ** ATRA expects to complete cuts by Jan 2026 ** Co expects ~$1.3 mln in layoff costs related to severance and other benefits ** Company says more charges may arise depending on events tied to layoffs ** Including session's move, stock up ~10% YTD (Reporting by Sahil Pandey in Bengaluru) ((Sahil.Pandey@thomsonreuters.com;))
Recent news on Atara Biotherapeutics
See all newsAtara Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atara Biotherapeutics Q2 revenue falls on deferred revenue recognition
Brief: Atara Biotherapeutics Q2 EPS USD -0.32
Atara Biotherapeutics, Inc. expected to post a loss of 31 cents a share - Earnings Preview
Brief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing